Effect of cyanate on red blood cell sickling.
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003485:Cyanates / Q000009:adverse effects / Q000627:therapeutic use*; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000378:metabolism; D006593:Hexokinase / Q000378:metabolism; D006801:Humans; D051379:Mice; D010732:Phosphofructokinase-1 / Q000378:metabolism; D011770:Pyruvate Kinase / Q000378:metabolism; D012098:Reproduction / Q000187:drug effects; D012975:Sodium Isotopes
D003485:Cyanates; D012975:Sodium Isotopes; D005954:Glucosephosphate Dehydrogenase; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D006593:Hexokinase; D010732:Phosphofructokinase-1; D011770:Pyruvate Kinase